Cargando…
Analysis of Frailty Syndrome in Men with Metastatic Prostate Cancer: A Scoping Review
Most patients with metastatic prostate cancer (mPCa) are older. In addition, current geriatric oncology guidelines suggest that all cancer patients aged over 70 years should undergo a comprehensive geriatric assessment (CGA), with the identification of frailty syndrome being crucial for clinical dec...
Autores principales: | Mafla-España, Mayra Alejandra, Torregrosa, María Dolores, Cauli, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964735/ https://www.ncbi.nlm.nih.gov/pubmed/36836553 http://dx.doi.org/10.3390/jpm13020319 |
Ejemplares similares
-
Comparison of Frailty Criteria, Cognitive Function, Depressive and Insomnia Symptoms in Men with Localized and Advanced Prostate Cancer under Androgen Deprivation Therapy
por: Mafla-España, Mayra Alejandra, et al.
Publicado: (2023) -
Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors
por: García-Sánchez, Javier, et al.
Publicado: (2022) -
Plasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer
por: García-Sánchez, Javier, et al.
Publicado: (2022) -
Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy
por: Mafla-España, Mayra Alejandra, et al.
Publicado: (2023) -
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study
por: García-Sánchez, Javier, et al.
Publicado: (2022)